Le Lézard
Classified in: Health
Subject: PDT

Building internal DIY Neurolab Capabilities



FLEMINGTON, N.J., Jan. 3, 2018 /PRNewswire/ -- HCD Research has launched a consumer neuroscience business unit focusing on installing neuroscience laboratories in corporate testing facilities and supporting client efforts in leveraging neuroscience to optimize products.  Lead by expert members Dr. Michelle Niedziela (neuroscientist, Director of Innovation & Technology) and Bill Thau (Director of Technology), this new business will help clients:

Dr. Niedziela stated, "Applied consumer neuroscience, or neuromarketing, is permeating the consumer product industry and it is necessary to apply a variety of methodologies and services based on the research and development objectives of companies."  For a number of organizations, HCD Research will execute projects from product inception to production and make recommendations towards product business decisions.  For other segments of clients, we will help establish capabilities to allow companies to quickly collect data in their own facility and HCD will rapidly analyze neuroscience metrics and report to our clients.

HCD Research conducts combined consumer neuroscience and traditional methods worldwide.  Since 2010 the company has pioneered methods for studying the subconscious response to product experience.

HCD Research

 

SOURCE HCD Research, Inc.


These press releases may also interest you

at 01:54
APRINOIA Therapeutics Inc., a clinical-stage neuroscience biotech company, focuses on tau, alpha-synuclein, and novel targets for neurodegenerative diseases, announces today the completion of its US$11.1 million Series B round. The Series B round was...

at 01:21
Novartis announced today results from the head-to-head CLARITY study demonstrating the superiority of Cosentyx® (secukinumab) compared to Stelara® (ustekinumab) in delivering clear and almost clear skin in adults with moderate to severe plaque...

at 01:20
Sandoz, a Novartis division and the global leader in biosimilar medicines, announced today that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA), submitted under the 351 (k) pathway, for proposed...

15 jan 2018
Therap is offering interactive workshops for its National Conference attendees from the state of Nebraska providing community based services to individuals with intellectual and developmental disabilities that receive funding from the State of...

15 jan 2018
The health and safety of more than 520,000 Rohingya children living in overcrowded camps and informal settlements in Bangladesh is likely to be put at even greater risk ahead of upcoming cyclone and monsoon seasons, UNICEF warned today. "As we...

15 jan 2018
Today, the Canadian Medical Association Journal Open published a study from the University of Waterloo entitled, Adverse effects of caffeinated energy drinks among youth and young adults in Canada: a Web-based survey. The Canadian Beverage...




News published on 3 january 2018 at 11:00 and distributed by: